Eric Guillemard, PhD
Current affiliation:
Danone Research, France
Recent publications:
- Guillemard E, Tanguy J, Flavigny A, de la Motte S, Schrezenmeir J. Effects of Consumption of a Fermented Dairy Product Containing the Probiotic Lactobacillus casei DN-114 001 on Common Respiratory and Gastrointestinal Infections in Shift Workers in a Randomized Controlled Trial. J Am Coll Nutr. 2010 Oct;29(5):455-468.
- Guillemard E, Tondu F, Lacoin F, Schrezenmeir J. 2010. Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Br. J. Nutr., 103, 58-68.
- Boge T, Rémigy M, Vaudaine S, Tanguy J, Bourdet-Sicard R, van der Werf S: A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 27:5677-5684, 2009.
Expertise and research area:
Efect on health of probiotics and probiotic products, dairy fermented product containing probiotic strains, respiratory and gastro-intestinal infections, mechanisms related to the modulation of the immune system.







